Literature DB >> 31403556

Number of Antibody-verified Eplet in HLA-C Locus as an Independent Factor of T-cell-Mediated Rejection After Liver Transplantation.

Sandra Guiral1, David San Segundo1, Juan Irure1, Fernando Casafont2, Jose Ignacio Fortea2, Ángela Puente2, Marcos López-Hoyos1, Javier Crespo2, Emilio Fabrega2.   

Abstract

BACKGROUND: HLA mismatching is a risk factor for graft rejection in solid organ transplantation. Its definition is being rethought with the introduction of the eplets in organ allocation. The eplets are highly polymorphic regions of the HLA molecule that help to explain cross-reactivity of HLA antigens. The effect of eplet mismatch is well documented in renal and lung transplantation but there is no clear evidence in liver transplantation.
METHODS: Forty-three consecutive liver-graft donor/recipient pairs performed at our center from 2016 to 2018 were HLA typed. The quantification of antibody-verified eplets (VerEp) mismatch was performed with HLA-matchmaker 2.1 version.
RESULTS: A total of 9 patients suffered an episode of T-cell-mediated rejection (TCMR). No significant differences were observed in the number of A, B, DRB, DQA, and DQB VerEp. However, the mean of mismatches VerEp in locus C (VerEpC) was significantly increased in patients with acute rejection: 3.89 (1.36) versus 2.32 (1.82), P = 0.021. A total of 22 patients with high load of VerEpC (>2) had an increased risk of TCMR (P = 0.008). The time of TCMR-free after liver transplant was statistically reduced in high-load VerEpC group (log-rank test P = 0.019). Multivariate analysis demonstrated that high load of VerEpC was independently associated with TCMR (P = 0.038).
CONCLUSIONS: Patients with no or 1 eplet mismatch at the C locus are less likely to suffer TCMR after liver transplantation.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31403556     DOI: 10.1097/TP.0000000000002921

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  1 in total

1.  Combined Analysis of HLA Class II Eplet Mismatch and Tacrolimus Levels for the Prediction of De Novo Donor Specific Antibody Development in Kidney Transplant Recipients.

Authors:  Hyeyoung Lee; Ji Won Min; Hyunhye Kang; Hanbi Lee; Sang Hun Eum; Yohan Park; Chul Woo Yang; Byung Ha Chung; Eun-Jee Oh
Journal:  Int J Mol Sci       Date:  2022-07-01       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.